Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study to Evaluate Safety of Nutriseal™ Nutriplace™ System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients must be \>21 years of age~2. Patients must require placement of a nasoenteral feeding tube~3. Patients have an endotracheal tube, OR Do not have an endotracheal tube but are sedated (RASS score of -2 or less) and/or obtunded (Glasgow Coma scale of 9-12)~4. Patients or legal authorized representative must be able to understand and adhere to all protocol procedures and be willing and able to provide written informed consent~Exclusion Criteria:~1. Patients must not have a history of:~   * Esophageal varices or ulcers~  * Upper airway obstruction~  * Upper GI stenosis or obstruction~  * Trauma involving sinuses, nares face or neck that would prevent Nasogastriv (NG) tube insertion~  * Deformities of the sinus cavities and/or skull base~  * Esophageal cancer or neoplasm~2. Patients must not have a significant concomitant illness that would adversely affect their participation in the study~3. Female patients who are pregnant or lactating

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nutriplace™ System (Type: EXPERIMENTAL): Placement of the Nutriseal™ Enteral Feeding Tube in the stomach or small intestine of adult patients who require feedings via the oro/nasoenteric route, using the Nutriplace™ System.

Based on this trial design, predict the completion outcome and termination type (if applicable).